What exactly does 'possibly carcinogenic to humans' (Group 2B) mean?

IARC Group 2B is the classification for agents where there is limited evidence of carcinogenicity in humans and less-than-sufficient evidence in animal studies. It reflects uncertainty rather than established harm. Other Group 2B agents include coffee (later moved to Group 3, 'not classifiable'), pickled Asian vegetables, aloe vera leaf extract, lead, and gasoline engine exhaust at low concentrations. The 2B classification is an active instruction to do more research, not a conclusion that the agent causes cancer.

Has anything changed since the 2011 IARC classification?

Yes. The 2024 WHO-commissioned systematic review by Karipidis and colleagues at ARPANSA pooled 63 studies on mobile phone use and brain tumours. It found no association at population level. The 2011 IARC classification was based largely on the Interphone study, which had a hypothesis-generating signal in the highest-exposure subgroup but inconsistent results overall. IARC may revisit the 2B classification in a future monograph; as of 2026 the classification stands but the empirical support has weakened, not strengthened.

What's the actual mechanism by which RF-EMF could cause harm?

At the exposure levels people encounter from mobile networks and Wi-Fi, the established biological effect is thermal — gentle warming of tissue. Australian and international regulatory limits are designed to keep that warming about 50× below any level shown to cause tissue damage. A non-thermal mechanism of harm has been proposed in some studies but has not been reliably reproduced in human research. Blinded provocation testing of self-reported electromagnetic hypersensitivity has not, under controlled conditions, demonstrated that subjects can detect when RF-EMF is on or off.

Should I reduce my mobile phone or Wi-Fi exposure?

ARPANSA's current position is that no precautionary measure is required at exposure below the regulatory limits. For peace-of-mind or thermal-comfort reasons, using speakerphone or wired earphones for long calls, keeping the phone away from the body during the day, and minimising bedside wireless devices are all zero-harm and may reduce a person's worry. These are choices, not clinical recommendations.

Where do the loudest 'wireless causes cancer' claims come from?

Most rest on three threads: the 2011 IARC 2B classification (covered above), the 2018 NTP rat study (which exposed rats whole-body to RF doses about 50× above the human regulatory limit for two years and found small numbers of heart-tissue tumours in male rats — the FDA, NIEHS, ARPANSA, and the European Commission's SCENIHR have all concluded this does not demonstrate human risk at typical exposure), and the Interphone study (mixed results overall, with the highest-exposure subgroup signal not replicating in subsequent population studies). The 'wireless is a carcinogen' headline collapses uncertainty into a definite statement that the underlying data does not justify.

Radiofrequency electromagnetic field exposure

Are wireless frequencies a carcinogen? The honest IARC 2B story

By Dr HB Lo, FACRRM Reviewed 16 May 2026 5 min read

Wireless radiofrequency electromagnetic fields (RF-EMF — what mobile phones, Wi-Fi, and broadcast radio use) were classified by IARC in 2011 as Group 2B, "possibly carcinogenic to humans" — same category as coffee, pickled vegetables, and aloe vera extract.

Group 2B reflects limited evidence in humans and inconclusive evidence in animals — an instruction to do more research, not a finding of causation. A 2024 WHO-commissioned systematic review of 63 studies on mobile phone use and brain tumours found no association at population level.

AU position via ARPANSA, NHMRC, and Cancer Council Australia: at exposure below regulatory limits, no adverse effect established.

The short version

In 2011, the International Agency for Research on Cancer classified radiofrequency electromagnetic fields — the non-ionising radiation emitted by mobile phones, Wi-Fi, broadcast radio, and similar wireless technology — as Group 2B: “possibly carcinogenic to humans.”

That classification has been the central data point for more than a decade of public debate. It is also one of the most misunderstood pieces of scientific information in environmental health.

This page covers what 2B means, what’s changed since 2011, and where Australian regulatory bodies — ARPANSA, NHMRC, Cancer Council Australia — currently sit. For a deeper dive on 5G specifically (the same evidence base, but with extra detail on millimetre-wave frequencies and the AU regulatory framework), see 5G and health: what the radiofrequency evidence actually shows.

A. What “Group 2B” actually means

The IARC classification system:

Group	Meaning	Sample agents
1	Carcinogenic to humans	Tobacco, asbestos, processed meat, ionising radiation
2A	Probably carcinogenic	Red meat, shift work with circadian disruption, glyphosate
2B	Possibly carcinogenic	RF-EMF, pickled vegetables, aloe vera leaf extract, lead, gasoline engine exhaust at low concentrations
3	Not classifiable	Coffee (moved here from 2B), printing inks, fluorescent lighting
4	Probably not carcinogenic	(Only one agent has been placed here)

Group 2B reflects scientific uncertainty. It means there is limited evidence in human studies and less-than-sufficient evidence in animal models — not enough to establish causation, not little enough to rule it out. It is an active research recommendation, not a conclusion.

The 2011 RF-EMF classification was driven largely by the Interphone study, a multi-country case-control investigation of mobile-phone use and glioma. The overall results were inconsistent. The hypothesis-generating signal was in the highest 10% of cumulative-use exposure, but it did not replicate across study populations and had several methodological caveats (recall bias, exposure misclassification).

B. What has changed since 2011

The body of evidence has grown substantially. Three findings are worth weighting in 2026.

The 2024 systematic review by Karipidis and colleagues. Commissioned by the WHO and conducted at ARPANSA, this systematic review pooled 63 studies on mobile phone use and brain tumours. It found no association at population level. This is the most methodologically robust synthesis of the human evidence to date and represents the current scientific consensus position.

The 2018 National Toxicology Program rat study. Often cited as evidence of harm: rats exposed whole-body to RF at high doses (about 50× above the human regulatory limit) for two years developed small numbers of malignant heart-tissue tumours (schwannomas) — male rats only, with no consistent effect in females or in mice. The FDA, NIEHS, ARPANSA, and SCENIHR have all reviewed the study and concluded the exposure conditions do not translate to human risk at typical mobile-network exposure levels.

Provocation testing of electromagnetic hypersensitivity. Multiple blinded trials over the past 15 years have not shown that people who self-identify as electromagnetic-hypersensitive can detect when RF-EMF is on or off, nor that their symptoms correlate with actual exposure rather than perceived exposure. This does not negate the lived experience of symptoms — those are real — but it does not support RF-EMF as the cause. Symptoms warrant a clinical workup for more probable causes (sleep, mood, blood pressure, thyroid, medication effects) rather than environmental attribution alone.

C. The current Australian regulatory position

ARPANSA sets Australian RF exposure limits via the Radio Frequency Standard RPS S-1, which adopts the ICNIRP 2020 guidelines. These limits cover mobile phones, base stations, Wi-Fi, Bluetooth, and 5G — all non-ionising radiofrequency sources — and include a safety margin of approximately 50× below any level shown to cause tissue heating.

NHMRC periodically reviews the evidence base and to date has not departed from the ICNIRP framework. Cancer Council Australia maintains a patient-facing summary that aligns with the regulatory position: no established adverse health effect from RF-EMF at exposure below the regulatory limits.

The Department of Health’s mobile communications resource covers the same ground at consumer level.

(MBS / PBS items verified 2026-05-16 via WebSearch — not directly applicable here, as this is environmental regulation rather than clinical-services policy.)

D. What a sensible reader can do with this

For someone asking the underlying question — should I be worried, and what should I do? — the AU-aligned answer in 2026:

No, at current exposure levels and the current standard of evidence. ARPANSA, NHMRC, Cancer Council Australia, and the WHO-commissioned 2024 systematic review all align on this.
The science is not closed. Some sub-questions remain genuinely open — long-term effects of millimetre-wave 5G specifically, cumulative lifetime paediatric exposure, and exposure during pregnancy. ARPANSA and ICNIRP both flag these as active research priorities.
Zero-harm precautionary choices exist for anyone who wants them: speakerphone or wired earphones in long calls, phone off the body during the day, minimising bedside wireless devices. These are choices, not clinical recommendations.
Spending substantially on unverified shielding products (EMF-blocking jewellery, pendants, “5G-protection” devices) is not supported by AU primary-tier conclusions and may divert resources from more impactful changes.
If symptoms are present and attributed to RF, a clinical workup for the more probable causes comes first. The differential diagnosis for fatigue, headache, sleep disturbance, palpitations, and similar symptoms does not start with environmental RF-EMF.

For a fuller treatment with the AU regulatory citations and the specific 5G discussion, see 5G and health: what the radiofrequency evidence actually shows.

What this article is and is not

This is general health information drawn from current Australian regulatory positions (ARPANSA, NHMRC, Department of Health, Cancer Council Australia), international guidance (ICNIRP, WHO, IARC), and recent peer-reviewed reviews. It is not personal medical advice and does not create a doctor–patient relationship. Decisions about specific health concerns or symptoms attributed to environmental exposures are made with your own GP, who can examine you and take a history.

Sources cited

Frequently asked questions

What exactly does 'possibly carcinogenic to humans' (Group 2B) mean?

IARC Group 2B is the classification for agents where there is limited evidence of carcinogenicity in humans and less-than-sufficient evidence in animal studies. It reflects uncertainty rather than established harm. Other Group 2B agents include coffee (later moved to Group 3, 'not classifiable'), pickled Asian vegetables, aloe vera leaf extract, lead, and gasoline engine exhaust at low concentrations. The 2B classification is an active instruction to do more research, not a conclusion that the agent causes cancer.
Has anything changed since the 2011 IARC classification?

Yes. The 2024 WHO-commissioned systematic review by Karipidis and colleagues at ARPANSA pooled 63 studies on mobile phone use and brain tumours. It found no association at population level. The 2011 IARC classification was based largely on the Interphone study, which had a hypothesis-generating signal in the highest-exposure subgroup but inconsistent results overall. IARC may revisit the 2B classification in a future monograph; as of 2026 the classification stands but the empirical support has weakened, not strengthened.
What's the actual mechanism by which RF-EMF could cause harm?

At the exposure levels people encounter from mobile networks and Wi-Fi, the established biological effect is thermal — gentle warming of tissue. Australian and international regulatory limits are designed to keep that warming about 50× below any level shown to cause tissue damage. A non-thermal mechanism of harm has been proposed in some studies but has not been reliably reproduced in human research. Blinded provocation testing of self-reported electromagnetic hypersensitivity has not, under controlled conditions, demonstrated that subjects can detect when RF-EMF is on or off.
Should I reduce my mobile phone or Wi-Fi exposure?

ARPANSA's current position is that no precautionary measure is required at exposure below the regulatory limits. For peace-of-mind or thermal-comfort reasons, using speakerphone or wired earphones for long calls, keeping the phone away from the body during the day, and minimising bedside wireless devices are all zero-harm and may reduce a person's worry. These are choices, not clinical recommendations.
Where do the loudest 'wireless causes cancer' claims come from?

Most rest on three threads: the 2011 IARC 2B classification (covered above), the 2018 NTP rat study (which exposed rats whole-body to RF doses about 50× above the human regulatory limit for two years and found small numbers of heart-tissue tumours in male rats — the FDA, NIEHS, ARPANSA, and the European Commission's SCENIHR have all concluded this does not demonstrate human risk at typical exposure), and the Interphone study (mixed results overall, with the highest-exposure subgroup signal not replicating in subsequent population studies). The 'wireless is a carcinogen' headline collapses uncertainty into a definite statement that the underlying data does not justify.

Source quality

Sources grouped by evidence tier. AU primary tier first; international where AU is silent or lagging; named-author reconstruction where guidelines have not yet caught up. How tiers work.

T1 AU primary 5 sources
T2 International primary 5 sources
T3 Named-author reconstruction 1 source
- Karipidis et al. — Mobile phone use and brain tumours systematic review (Environ Int 2024)